Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-Positive Solid Tumor
Interventions: DRUG: YH32367
Sponsor: Yuhan Corporation